18F-FDG uptake in the stomach on screening PET/CT: value for predicting Helicobacter pylori infection and chronic atrophic gastritis

BackgroundThe aim of this study was to determine the value of 18F-FDG uptake on screening PET/CT images for the prediction of Helicobacter pylori (H. pylori) infection and chronic atrophic gastritis.MethodsAmong subjects who underwent 18F-FDG PET/CT for cancer screening from April 2005 to November 2015, PET/CT images were analyzed in 88 subjects who had gastrointestinal fiberscopy within 6 months. The volumes of interest (VOIs) were placed in the fornix, corpus and antrum of the stomach to determine maximal standardized uptake value (SUVmax) and mean SUV (SUVmean). Receiver operating characteristic curve (ROC) analysis was performed to determine the diagnostic performance of SUV indicators in predicting H. pylori infection and chronic atrophic gastritis.ResultsSUV indicators of the stomach were significantly higher in subjects with H. pylori infection than those without (from P < 0.001 to P < 0.05). ROC analysis revealed that SUVmean had the highest performance in predicting H. pylori infection (AUC 0.807) and chronic atrophic gastritis (AUC 0.784). SUVmean exhibited the sensitivity of 86.5 % and the specificity of 70.6 % in predicting H. pylori infection, and the sensitivity of 75.0 % and 78.6 % in predicting chronic atrophic gastritis.ConclusionAssessment of 18F-FDG uptake in the stomach reflecting active inflammation is useful in predicting patients with H. pylori infection and subsequent chronic atrophic gastritis which is closely associated with the risk of gastric neoplasms.

[1]  M. Hickeson,et al.  PET/Computed Tomography in the Diagnosis and Staging of Gastric Cancers. , 2015, PET clinics.

[2]  Abass Alavi,et al.  18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. , 2002, Seminars in nuclear medicine.

[3]  T. Alempijevic,et al.  Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions. , 2015, World journal of gastroenterology.

[4]  H. Kim,et al.  Correlation of Primary Tumor FDG Uptake with Histopathologic Features of Advanced Gastric Cancer , 2015, Nuclear Medicine and Molecular Imaging.

[5]  R. Fujita,et al.  Significance of 18F-2-deoxy-2-fluoro-glucose accumulation in the stomach on positron emission tomography , 2009, Annals of nuclear medicine.

[6]  Evaluation of 18F-2-deoxy-2-fluoro-glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopy , 2007, British Journal of Cancer.

[7]  M. Senda,et al.  Performance profile of a FDG-PET cancer screening program for detecting gastric cancer: results from a nationwide Japanese survey , 2014, Japanese Journal of Radiology.

[8]  Z. Keidar,et al.  PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  K. Ohshima,et al.  Comparison Between Endoscopic Macroscopic Classification and F-18 FDG PET Findings in Gastric Mucosa–Associated Lymphoid Tissue Lymphoma Patients , 2012, Clinical nuclear medicine.

[10]  G. V. von Schulthess,et al.  Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  Te-Chun Hsieh,et al.  Positive Correlation Between Standardized Uptake Values of FDG Uptake in the Stomach and the Value of the C-13 Urea Breath Test , 2006, Clinical nuclear medicine.

[12]  A. Tukiendorf,et al.  Prognostic value and clinical correlations of 18-fluorodeoxyglucose metabolism quantifiers in gastric cancer. , 2015, World journal of gastroenterology.

[13]  Seung Wan Ryu,et al.  Preoperative Standardized Uptake Value of Metastatic Lymph Nodes Measured by 18F-FDG PET/CT Improves the Prediction of Prognosis in Gastric Cancer , 2015, Medicine.

[14]  G. Rubini,et al.  18F-FDG PET/CT Role in Staging of Gastric Carcinomas: Comparison with Conventional Contrast Enhancement Computed Tomography , 2015, Medicine.

[15]  Deng-Chyang Wu,et al.  Diagnosis of Helicobacter pylori infection: Current options and developments. , 2015, World journal of gastroenterology.

[16]  M. Sasaki,et al.  An analysis of the physiological FDG uptake pattern in the stomach , 2003, Annals of nuclear medicine.

[17]  Ç. Soydal,et al.  The Role of 18F-FDG PET/CT in the Primary Staging of Gastric Cancer , 2015, Molecular imaging and radionuclide therapy.

[18]  M. Yun.  Imaging of Gastric Cancer Metabolism Using 18 F-FDG PET/CT , 2014, Journal of gastric cancer.

[19]  M. Blaser,et al.  Gastric adenocarcinoma and Helicobacter pylori infection. , 1991, Journal of the National Cancer Institute.

[20]  B. Tonge,et al.  Patterns of Depressive Symptoms and Social Relating Behaviors Differ Over Time From Other Behavioral Domains for Young People With Down Syndrome , 2015, Medicine.

[21]  Jing Cui,et al.  Evaluation of Dual Time Point Imaging 18F-FDG PET/CT in Differentiating Malignancy From Benign Gastric Disease , 2015, Medicine.

[22]  K. Matsuo,et al.  Declining trends in prevalence of Helicobacter pylori infection by birth‐year in a Japanese population , 2015, Cancer science.

[23]  R L Wahl,et al.  Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.